Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva b.v. - dasatinibmonohydrate - filmdragerad tablett - 50 mg - dasatinibmonohydrate 51,847 mg aktiv substans; laktosmonohydrat hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva b.v. - dasatinibmonohydrate - filmdragerad tablett - 20 mg - dasatinibmonohydrate 20,739 mg aktiv substans; laktosmonohydrat hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva b.v. - dasatinibmonohydrate - filmdragerad tablett - 80 mg - laktosmonohydrat hjälpämne; dasatinibmonohydrate 82,954 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva b.v. - dasatinibmonohydrate - filmdragerad tablett - 70 mg - laktosmonohydrat hjälpämne; dasatinibmonohydrate 72,585 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva b.v. - dasatinibmonohydrate - filmdragerad tablett - 100 mg - laktosmonohydrat hjälpämne; dasatinibmonohydrate 103,693 mg aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastiska medel - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Europeiska unionen - svenska - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyom - hypofysiska och hypotalamiska hormoner och analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Europeiska unionen - svenska - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirala medel för systemisk användning - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 och 5. tecovirimat siga should be used in accordance with official recommendations.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

paranova läkemedel ab - doxycyklinmonohydrat - kapsel med modifierad frisättning, hård - 40 mg - allurarött ac aluminiumlack hjälpämne; sockersfärer hjälpämne; propylenglykol hjälpämne; doxycyklinmonohydrat 10,42 mg aktiv substans; doxycyklinmonohydrat 31,2 mg aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, non-small cell lung - antineoplastiska medel - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.